HIMA (Health Industry Manufacturers Association) calls for politicians to use "sound science"
This article was originally published in Clinica
Executive Summary
The US Health Industry Manufacturers Association (HIMA) has sent a letter to members of Congress asking them to ensure that the regulation of medical devices is based on sound science. The letter, signed by newly-installed HIMA president Pamela Bailey, refers to the recent report by the Institute of Medicine finding no link between silicone breast implants and chronic disease and the report by former US surgeon general Dr Everett Koop confirming the safety of vinyl in medical products (see Clinica No 864, pp 14 and 15). Both these reports show the importance of weighing the scientific research instead of rushing to judgement based on inconclusive or inappropriate junk science. Such a rush helped precipitate the biomaterials shortage a few years ago, Ms Bailey noted.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.
Over The Counter 2 Apr 2024: Analyzing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen
In this episode, HBW Insight’s Europe and US editors bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago; Kenvue, soon to celebrate its first anniversary as a new company; Sanofi Consumer Healthcare, which is poised to split from its pharma parent; and Bayer, which has decided to buck the trend, holding on to its consumer health division. We discuss some of the advantages of becoming a standalone company, for example in leaning into a wider concept of self-care.